Trial Profile
Safety and immunogenicity of 7-valent pneumococcal conjugate vaccine among solid organ transplant recipients: protocol 1A and 1B
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Feb 2021
Price :
$35
*
At a glance
- Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Adverse reactions; Pharmacodynamics
- 10 Feb 2021 Status changed from active, no longer recruiting to completed.
- 11 Nov 2005 New trial record.